Gur joined Venrock in 2008. Previously, he was a vice president and senior research analyst at Piper Jaffray & Co., focusing on specialty pharmaceuticals and small cap biotech companies. In this role, Gur was responsible for analyzing, valuing and publishing research on both publicly traded and privately held biotech and specialty pharmaceutical companies. Gur was trained in internal medicine at the Mount Sinai Medical Center, New York, where he also served as chief resident, and subsequently spent several years in private practice as an internist in New York.
Gur received his B.A. from Columbia University, M.B.A. from Leonard N. Stern School of Business and M.D. from Albert Einstein College of Medicine.